FRANKLIN LAKES, N.J., Oct. 22, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13. Byington, 58, is executive vice president and head of University of California Health (UCH), where she... Read more
Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1 The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study. This new test expands Roche’s... Read more
SANTA CLARA, Calif., October 21, 2021 Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and... Read more
SANTA CLARA, Calif., October 13, 2021 Agilent Technologies Inc. (NYSE: A) today announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio® (abemaciclib) in combination with endocrine therapy is being considered.... Read more
First-of-its-kind tool actively manages hospital data, providing near real-time occupancy information that enables hospitals to maximize resources Saved participating hospitals 45,000 hours of labor, amounting to $3 million dollars, by eliminating the need for manual entry of capacity data Puts actionable data in the hands of decision-makers so that statewide capacity can be optimized, allowing... Read more
Existing CHO platform, featuring low cost and no royalty or license tie-ins, expands with new cell line to help develop biotherapeutics with increased potency and longevity and decreased side effects WALTHAM, Mass.– October 6, 2021, PerkinElmer Inc., a global leader committed to innovating for a healthier world, today announced that its Horizon Discovery CHOSOURCE™ platform is... Read more
Trial met primary endpoint, showing Ronapreve significantly reduced viral load in seronegative patients hospitalised with COVID-19 who did not require high-flow oxygen or mechanical ventilation at baseline Clinical data complement previous findings in hospitalised setting, including from United Kingdom (UK) University of Oxford-led RECOVERY trial Basel, 30 September 2021 – Roche (SIX: RO, ROG; OTCQX:... Read more
Thermo Fisher Scientific Opens Call for Grant Proposals to Fund Clinical Research in Hematology-oncology CARLSBAD, Calif., Sept. 29, 2021 /PRNewswire/ — To support clinical research needs using next-generation sequencing (NGS), Thermo Fisher Scientific today announced it is accepting new submissions for its Oncomine Clinical Research Grant. The latest call for proposals aims to provide funding for... Read more
Thermo Fisher Scientific Unveils New Clinical and Research Lab Innovations at AACC 2021 New instruments, assays and controls improve speed, sensitivity and flexibility for clinical testing and research related to COVID-19, cell & gene therapy, autoimmune disease and drugs of abuse ATLANTA, Sept. 28, 2021 /PRNewswire/ — AACC 2021 –Thermo Fisher Scientific, the world leader in... Read more